Literature DB >> 32798493

Chronic pancreatitis.

Georg Beyer1, Aida Habtezion2, Jens Werner3, Markus M Lerch4, Julia Mayerle5.   

Abstract

Chronic pancreatitis is a multifactorial, fibroinflammatory syndrome in which repetitive episodes of pancreatic inflammation lead to extensive fibrotic tissue replacement, resulting in chronic pain, exocrine and endocrine pancreatic insufficiency, reduced quality of life, and a shorter life expectancy. The incidence and prevalence of chronic pancreatitis is rising and no curative treatment is available. Using novel diagnostic algorithms, definitive chronic pancreatitis can be diagnosed by imaging criteria alone, whereas probable chronic pancreatitis requires clinical features and imaging criteria. Criteria for the diagnosis of early chronic pancreatitis are still under discussion and need prospective validation in clinical trials. Cross-sectional imaging should be used first; endoscopic ultrasound is needed only when CT or MRI are inconclusive or to plan therapeutic interventions. Management of chronic pancreatitis requires an interdisciplinary approach including primary care practitioners, gastroenterologists, surgeons, radiologists, pain specialists, and nutritional therapists. Patients with chronic pancreatitis should be seen at least once a year and re-evaluated for causal risk factors, symptom control, and complications such as malnutrition, pancreatic exocrine insufficiency, and diabetes; refer to a specialised centre if symptoms are poorly controlled or there is risk of deterioration. Scoring systems to monitor disease progression have been developed and validated internationally. Interventional treatments for pain or cholestasis should be done by specialists only, and early discussion of treatment approaches should include all medical disciplines involved in care. Throughout this Seminar, we address research needs such as staging of pancreatitis, aspects of malnutrition and pain, and cancer surveillance, to help improve the care of patients.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32798493     DOI: 10.1016/S0140-6736(20)31318-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  51 in total

Review 1.  [Diagnostics and clinical management of premalignant diseases of the pancreas].

Authors:  S M Buchholz; C Ammer-Herrmenau; V Ellenrieder; A Neesse
Journal:  Internist (Berl)       Date:  2022-03-02       Impact factor: 0.743

Review 2.  The deleterious effects of smoking on the development and progression of chronic pancreatitis.

Authors:  Samuel Y Han; Darwin L Conwell; Philip T Diaz; Amy Ferketich; Christie Y Jeon; Dhiraj Yadav; Phil A Hart
Journal:  Pancreatology       Date:  2022-08-11       Impact factor: 3.977

3.  Common calcium-sensing receptor (CASR) gene variants do not modify risk for chronic pancreatitis in a Hungarian cohort.

Authors:  Amanda Takáts; Gergő Berke; Andrea Szentesi; Gyula Farkas; Ferenc Izbéki; Bálint Erőss; László Czakó; Áron Vincze; Péter Hegyi; Miklós Sahin-Tóth; Eszter Hegyi
Journal:  Pancreatology       Date:  2021-08-26       Impact factor: 3.977

4.  Blockade of the protease ADAM17 ameliorates experimental pancreatitis.

Authors:  Mohamed I Saad; Teresa Weng; Joanne Lundy; Linden J Gearing; Alison C West; Christopher M Harpur; Mohammad Alanazi; Christopher Hodges; Daniel Croagh; Beena Kumar; Irit Sagi; Stefan Rose-John; Brendan J Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-10       Impact factor: 12.779

5.  Chemical pancreatectomy: an unconventional approach to preventing autodigestion in pancreatitis.

Authors:  Rodger A Liddle
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

Review 6.  Antioxidant Therapy in Pancreatitis.

Authors:  Lourdes Swentek; Dean Chung; Hirohito Ichii
Journal:  Antioxidants (Basel)       Date:  2021-04-23

Review 7.  Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer.

Authors:  Can Huang; Juan Iovanna; Patricia Santofimia-Castaño
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

8.  Puerarin Ameliorates Caerulein-Induced Chronic Pancreatitis via Inhibition of MAPK Signaling Pathway.

Authors:  Xiang-Peng Zeng; Jing-Hui Zeng; Xia Lin; Yan-Hong Ni; Chuan-Shen Jiang; Da-Zhou Li; Xiao-Jian He; Rong Wang; Wen Wang
Journal:  Front Pharmacol       Date:  2021-06-02       Impact factor: 5.810

Review 9.  Autoimmune pancreatitis and pancreatic cancer: Epidemiological aspects and immunological considerations.

Authors:  Dimitri Poddighe
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

Review 10.  Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma.

Authors:  Andrew Cannon; Christopher Michael Thompson; Rakesh Bhatia; Katharine Anne Armstrong; Joyce Christopher Solheim; Sushil Kumar; Surinder Kumar Batra
Journal:  J Gastroenterol       Date:  2021-07-19       Impact factor: 6.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.